Skip to main content
GutCited

락토바실루스 애시도필루스 그림

10 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1 Forest Plot

Forest plot summarizing the pooled efficacy of probiotic interventions across multiple gastrointestinal conditions, with odds ratios and confidence intervals for each included trial.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 2
Figure 2 Forest Plot

Subgroup analysis by probiotic strain type reveals differential efficacy, with Lactobacillus and Saccharomyces species showing the strongest associations with symptom improvement.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 3
Figure 3 Chart

Funnel plot assessment for publication bias in the probiotic meta-analysis indicates generally symmetric distribution of effect sizes around the pooled estimate.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 4
Figure 4 Forest Plot

Stratified forest plot examining probiotic efficacy specifically in antibiotic-associated diarrhea trials shows a significant protective effect compared to placebo.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 5
Figure 5 Forest Plot

Sensitivity analysis removing individual studies demonstrates that the overall positive association between probiotic supplementation and gastrointestinal symptom relief remains robust.

A meta-analysis of probiotic efficacy for gastrointestinal diseases.

Figure 1
Figure 1 Chart

Experimental results examining computational prediction of new therapeutic effects of probiotics, with data points illustrating key findings related to probiotics are living microorganisms that provide health benefits to their hosts, potentially aiding in the treatment.

Computational prediction of new therapeutic effects of probiotics.

Figure 2
Figure 2 Chart

Statistical analysis from research investigating computational prediction of new therapeutic effects of probiotics, comparing treatment groups and control conditions.

Computational prediction of new therapeutic effects of probiotics.

Figure 3
Figure 3 Chart

Measured parameters from a study evaluating computational prediction of new therapeutic effects of probiotics, contributing to the overall assessment of probiotics are living microorganisms that provide health benefits to their hosts, potentially aiding in the treatment.

Computational prediction of new therapeutic effects of probiotics.

Figure 4
Figure 4 Chart

Graphical representation of outcomes in a study of computational prediction of new therapeutic effects of probiotics, highlighting trends observed across experimental conditions.

Computational prediction of new therapeutic effects of probiotics.

Figure 5
Figure 5 Chart

Quantitative data from a study on computational prediction of new therapeutic effects of probiotics, presenting measured outcomes relevant to the investigation of probiotics are living microorganisms that provide health benefits to their hosts, potentially aiding in the treatment.

Computational prediction of new therapeutic effects of probiotics.